Connection

Solange Peters to Receptor Protein-Tyrosine Kinases

This is a "connection" page, showing publications Solange Peters has written about Receptor Protein-Tyrosine Kinases.
  1. EML4-ALK Variant Affects ALK Resistance Mutations. J Clin Oncol. 2018 04 20; 36(12):1257-1259.
    View in: PubMed
    Score: 0.158
  2. Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2017 08 31; 377(9):829-838.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.